WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

PHARMACEUTICAL SYNTHETIC REVIEW OF ROSUVASTATIN CALCIUM

Premchand Patil, Deepak V. Nagarale and *Bhata R. Chaudhari

Abstract

Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It was developed by Shionogi. The primary uses of rosuvastatin are for the treatment of dyslipidemia. It is recommended to be used only after other measures such as diet, exercise, and weight reduction have not improved cholesterol levels. Rosuvastatin has multiple contraindications which include hypersensitivity to rosuvastatin or any component of the formulation, active liver disease, and elevation of serum transaminases, pregnancy, or breast-feeding.

Keywords: Rosuvastatin is a member or breast-feeding.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More